Sign in
VOR Stock Price, Chart, Stats & News
Vor Biopharma Inc.
Save
Vor Biopharma Inc. (VOR) does not currently pay a dividend.
1.00B
Market cap
–
Current P/E
–
Forward P/E
VOR chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -1389.92% |
ROE | 274.58% |
D/E | -0.00x |
Interest coverage ratio | – |
VOR valuation
P/E | – |
P/S | – |
P/B | -0.04x |
P/CF | -0.67x |
P/FCF | -0.69x |
P/OCF | -0.67x |
PEG | 0.00x |
EV multiple | -0.23x |
About
Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies.
Similar securities
Based on sector and market capitalization
Report issue